1.33
-0.02(-1.48%)
Currency In USD
| Previous Close | 1.35 |
| Open | 1.34 |
| Day High | 1.39 |
| Day Low | 1.3 |
| 52-Week High | 4.18 |
| 52-Week Low | 0.6 |
| Volume | 163,261 |
| Average Volume | 333,841 |
| Market Cap | 60.81M |
| PE | -0.81 |
| EPS | -1.64 |
| Moving Average 50 Days | 1.25 |
| Moving Average 200 Days | 1.28 |
| Change | -0.02 |
If you invested $1000 in Werewolf Therapeutics, Inc. (HOWL) since IPO date, it would be worth $82.61 as of September 08, 2025 at a share price of $1.33. Whereas If you bought $1000 worth of Werewolf Therapeutics, Inc. (HOWL) shares 3 years ago, it would be worth $180.95 as of September 08, 2025 at a share price of $1.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 12:00 PM GMT
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
GlobeNewswire Inc.
Jul 09, 2025 12:00 PM GMT
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to s
Werewolf Therapeutics to Participate in the BIO International Convention
GlobeNewswire Inc.
Jun 12, 2025 12:00 PM GMT
WATERTOWN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to s